Cullinan Oncology, Inc. (CGEM)
USD 10.77
(-6.27%)
USD 10.77
(-6.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 18.94 Million | - | - | - |
| Cost of Revenue | 310 Thousand | 93 Thousand | 53 Thousand | 62 Thousand | 70 Thousand | 43 Thousand |
| Gross Profit | -310 Thousand | -93 Thousand | 18.89 Million | -62 Thousand | -70 Thousand | -43 Thousand |
| Operating Expenses | 191.08 Million | 132.13 Million | 86.89 Million | 60.33 Million | 22.27 Million | 14.58 Million |
| Selling, General and Administrative Expenses | 42.49 Million | 40.18 Million | 29.14 Million | 17.12 Million | 5.48 Million | 5 Million |
| Research and Development Expenses | 148.15 Million | 91.94 Million | 57.75 Million | 43.21 Million | 16.78 Million | 9.58 Million |
| Other Expenses | 440 Thousand | 57 Thousand | -8000.00 | -11 Thousand | -4000.00 | - |
| Cost and Expenses | 191.08 Million | 132.13 Million | 86.89 Million | 60.33 Million | 22.27 Million | 14.58 Million |
| Operating Income | -191.08 Million | 144.64 Million | -67.95 Million | -60.33 Million | -22.27 Million | -14.58 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -14.12 Million | 42.12 Million | -2.44 Million | -8.6 Million | -1.61 Million | 397 Thousand |
| Earnings before Tax | -169.22 Million | 151.31 Million | -67.48 Million | -59.45 Million | -21.65 Million | -14.18 Million |
| Net Income | -153.16 Million | 111.21 Million | -65.04 Million | -50.84 Million | -20.03 Million | -14.18 Million |
| Earnings Per Share Basic | -3.69 | 2.46 | -1.47 | -1.17 | -0.46 | -1.24 |
| Earnings Per Share Diluted | -3.69 | 2.38 | -1.47 | -1.17 | -0.46 | -1.24 |
| Weighted Average Shares Outstanding | 41.5 Million | 45.16 Million | 44.29 Million | 43.51 Million | 43.51 Million | 11.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.55 Million | 46.64 Million | 44.29 Million | 43.51 Million | 43.51 Million | 11.44 Million |
| Gross Margin | - | - | 1.00 | - | - | - |
| EBIT Margin | - | - | -3.59 | - | - | - |
| Profit Margin | - | - | -3.43 | - | - | - |
| EBITDA | -190.33 Million | 151.4 Million | -67.9 Million | -60.27 Million | -22.2 Million | -14.54 Million |
| Earnings Before Tax Margin | - | - | -3.59 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 77 Thousand | 76 Thousand | 77 Thousand | 310 Thousand | 80 Thousand | 81 Thousand |
| Gross Profit | -77 Thousand | -76 Thousand | -77 Thousand | -310 Thousand | -80 Thousand | -81 Thousand |
| Operating Expenses | 49.95 Million | 42.91 Million | 45.4 Million | 190.33 Million | 44.8 Million | 37.6 Million |
| Selling, General and Administrative Expenses | 13.69 Million | 12.26 Million | 10.56 Million | - | 10.98 Million | 10.21 Million |
| Research and Development Expenses | 36.25 Million | 30.64 Million | 34.84 Million | - | 33.82 Million | 27.39 Million |
| Other Expenses | -72 Thousand | -44 Thousand | -117 Thousand | - | 180 Thousand | 69 Thousand |
| Cost and Expenses | 50.02 Million | 42.98 Million | 45.48 Million | 190.64 Million | 44.8 Million | 37.6 Million |
| Operating Income | -50.02 Million | -42.98 Million | -45.48 Million | -190.64 Million | -45.24 Million | -37.6 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -192 Thousand | -14.12 Million | -14.12 Million | -5.44 Million | -5.4 Million |
| Earnings before Tax | -42.02 Million | -37.34 Million | -39.68 Million | -169.22 Million | -39.18 Million | -32.21 Million |
| Net Income | -42.02 Million | -37.14 Million | -23.8 Million | -153.16 Million | -39.18 Million | -32.21 Million |
| Earnings Per Share Basic | -0.76 | -0.86 | -0.56 | - | -0.92 | -0.81 |
| Earnings Per Share Diluted | -0.76 | -0.86 | -0.56 | - | -0.92 | -0.81 |
| Weighted Average Shares Outstanding | 55.05 Million | 43.01 Million | 42.79 Million | 41.55 Million | 42.73 Million | 39.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.05 Million | 43.01 Million | 42.79 Million | 41.55 Million | 42.73 Million | 39.95 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -49.95 Million | -42.91 Million | -45.4 Million | - | -44.28 Million | -37.6 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
BML-PJ
EEA
GWO
WEGRY
AMIH
1813